Melioidosis: Refining management of a tropical time bomb

by Fisher, D.A., Harris, P.N.A.
Published 2016

Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia c...

by Harris P.N.A., Yin M., Jureen R., Chew J., Ali J., Paynter S., Paterson D.L., Tambyah P.A.
Published 2018

Empiric piperacillin-tazobactam versus carbapenems in the treatment of bacteraemia due to extended-spectrum beta-lactamase-producing enterobacteriaceae

by Ng T.M., Khong W.X., Harris P.N.A., De P.P., Chow A., Tambyah P.A., Lye D.C.
Published 2018

Melioidosis, Singapore, 2003–2014

by Pang, L., Harris, P.N.A., Seiler, R.L., Ooi, P.L., Cutter, J., Goh, K.T., Cook, A.R., Fisher, D., Chai, L.Y.A.
Published 2021

Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacter spp, Citrobacter freundii, Morganella...

by Stewart, AG, Paterson, DL, Young, B, Lye, DC, Davis, JS, Schneider, K, Yilmaz, M, Dinleyici, R, Runnegar, N, Henderson, A, Archuleta, S, Kalimuddin, S, Forde, BM, Chatfield, MD, Bauer, MJ, Lipman, J, Harris-Brown, T, Harris, PNA
Published 2021